STTK Shattuck Labs Inc: Earnings per share for the last twelve months
Shattuck Labs, Inc. (STTK) relies on a strong team of immunologists and clinical experts, protecting its competencies through stock options. Developments are based on the ARC platform for creating hybrid proteins that block tumor defenses. Tracking the EPS trend over the last 12 months on GURU.Markets, we note that the -0.51 mark characterizes this parameter. The company's innovative drugs deliver a double blow to cancer, increasing therapy efficacy.
Analytical breakdowns and data insights for company Shattuck Labs, Inc. (STTK)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Shattuck Labs, Inc.|STTK - Long-Term Liabilities to Capital|Short-Term Debt to Equity Shattuck Labs Inc|STTK - Company Total Debt Obligations|Debts to Book Capitalization STTK|STTK - Company Long-Term Loans and Borrowings|Company Short-Term Debts Shattuck Labs|Quick Liquidity Indicator shattucklabs.com
- earnings and valuation multiples indicators:
STTK - Profit After Payment of Taxes|Future Profit Shattuck Labs, Inc.|STTK - Market Price to Net Income Ratio|Projected Price to Earnings Shattuck Labs, Inc.|STTK - PEG Multiple|EV/EBITDA Multiple STTK|STTK - Operating profit before deduction of amortization|Earnings per share for the last twelve months Shattuck Labs|STTK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months shattucklabs.com|STTK - Earnings per share increase in current year|Net earnings per share growth forecast for next year Shattuck Labs, Inc.
- sales and revenue data:
Fundamental company analysis:Shattuck Therapeutics (STTK)
For Shattuck Labs, Inc. (STTK), the company's trailing 12-month earnings per share serves as an indicator of fundamental efficiency. This metric is calculated by dividing the total annual net income by the total number of outstanding shares, allowing investors to filter out market noise and assess the real return on each share. For this immuno-oncology protein developer, this figure reflects its current stage of investment growth. EPS dynamics help determine the cost of capital while awaiting clinical trial results.
Competing companies
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Grifols - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (adaptivebiotech.com)|Celldex (CLDX) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Earnings per share for the last twelve months Pharming Group NV PHAR|Net earnings per share (EPS TTM) Nektar Therapeutics Inc NKTR|Upstream Bio, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ZBIO (Zenas Biopharma, Inc.)|immunome.com (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months gossamerbio.com (GOSS)|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
